Total Funding
29
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
180566
AMAG Pharmaceuticals is a biopharmaceutical company that provides solutions for patients with complex, underserved conditions.
Acquired by 
Covis Pharma
Robert Perez: Director of the Biomedical Science Careers ProgramPast Role: Cubist Pharmaceuticals, EVP and COO- William Heiden: CEOPast Role: Elixir Pharmaceuticals, CEO & President
About the Company
AMAG Pharmaceuticals is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
